Because of the high prevalence of dyslipoproteinemias and their association with atherosclerotic cardiovascular disease (CVD), measurements of plasm lipids, lipoproteins, and apolipoproteins are often required for diagnosis and follow-up of patients. We establish techniques for the phenotyping and quantitative measurement of Lp (a) and for the measurement of apolipoproteins A-1 and B.

Agency
National Institute of Health (NIH)
Institute
Clinical Center (CLC)
Type
Intramural Research (Z01)
Project #
1Z01CL010206-02
Application #
3774513
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
2
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Clinical Center
Department
Type
DUNS #
City
State
Country
United States
Zip Code